CD40-related receptor that binds CD40L
US7378492B2 · kind B2 · utility
10Cited by
19References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2003 |
| Grant date | May 27, 2008 |
| Priority date | — |
| Expiry date | Feb 18, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/28
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.